[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Geovax Labs Inc (GOVX)

Geovax Labs Inc (GOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,517
  • Shares Outstanding, K 3,473
  • Annual Sales, $ 2,490 K
  • Annual Income, $ -21,460 K
  • EBIT $ -21 M
  • EBITDA $ -20 M
  • 60-Month Beta 3.73
  • Price/Sales 0.95
  • Price/Cash Flow N/A
  • Price/Book 1.34
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -11.34
  • Most Recent Earnings $-0.97 on 07/27/26
  • Next Earnings Date 11/12/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-1.02
  • Number of Estimates 2
  • High Estimate $-0.96
  • Low Estimate $-1.09
  • Prior Year $-7.75
  • Growth Rate Est. (year over year) +86.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6388 +19.29%
on 07/28/26
1.2550 -39.28%
on 07/06/26
-0.4280 (-35.97%)
since 07/02/26
3-Month
0.6388 +19.29%
on 07/28/26
4.3900 -82.64%
on 05/18/26
-0.5080 (-40.00%)
since 05/04/26
52-Week
0.6388 +19.29%
on 07/28/26
20.0000 -96.19%
on 08/19/25
-18.6380 (-96.07%)
since 08/04/25

Most Recent Stories

More News
GeoVax Highlights Newly Published Independent Research Supporting Broader Filovirus Vaccine Strategies and Strategic Value of Its MVA-Based Vaccine Portfolio

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.7620 (+5.15%)
GeoVax Reports Second Quarter 2026 Financial Results and Provides Business Update

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.7620 (+5.15%)
GeoVax Highlights Strategic Alignment of GEO-MVA With HHS/ASPR's Five-Year Medical Countermeasure Preparedness Strategy

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.7620 (+5.15%)
GeoVax Highlights Continued U.S. Government Investment in Orthopox Preparedness as Strategic Validation of Long-Term Vaccine Readiness

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.7620 (+5.15%)
Is Co-Diagnostics National Security’s Next Diagnostic Pick?

Global health emergencies are shifting sovereign biodefense strategies toward decentralized diagnostic networks capable of deploying rapid stockpiles.

OSUR : 4.17 (+0.24%)
GOVX : 0.7620 (+5.15%)
CODX : 1.5100 (+2.03%)
Hard-to-Treat Cancers: How 2026’s Top Clinical Platforms Are Beating Industry Benchmarks

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – The global oncology market is charging toward a massive $668 billion valuation by 2034[1], fueled by a...

ONCY : 0.8105 (+4.58%)
FHTX : 4.86 (+5.42%)
ORIC : 13.47 (+27.08%)
LLY : 1,115.68 (-0.51%)
GOVX : 0.7620 (+5.15%)
SLS : 11.81 (+5.26%)
Roth MKM Sticks to Their Buy Rating for GeoVax Labs (GOVX)

Roth MKM analyst Jonathan Aschoff maintained a Buy rating on GeoVax Labs today and set a price target of $14.00. The company’s shares closed yesterday at $0.56.Elevate Your Investing Strategy: Take advantage...

GOVX : 0.7620 (+5.15%)
Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

/CNW/ -- As lawmakers weigh potential cuts to scientific research funding, the outlook for developing cancer cures faces growing uncertainty. The situation is...

ONCY : 0.8105 (+4.58%)
ZLAB : 18.49 (+1.71%)
GOVX : 0.7620 (+5.15%)
SLS : 11.81 (+5.26%)
ONC.TO : 1.42 (+2.16%)
OSTX : 1.6300 (+5.16%)
Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Equity Insider News Commentary

ONCY : 0.8105 (+4.58%)
ZLAB : 18.49 (+1.71%)
GOVX : 0.7620 (+5.15%)
SLS : 11.81 (+5.26%)
ONC.TO : 1.42 (+2.16%)
OSTX : 1.6300 (+5.16%)
ZAILF : N/A (N/A)
World Cancer Day Sparks Big Questions About Pollution, Genetics, and Innovation

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As World Cancer Day (Feb. 4) fades into the rearview, attention is shifting to the latest discussions...

ONCY : 0.8105 (+4.58%)
ZNTL : 4.88 (+4.95%)
NYT : 75.61 (+0.23%)
ABSI : 8.48 (+6.94%)
GOVX : 0.7620 (+5.15%)
ONC.TO : 1.42 (+2.16%)
GSK : 51.53 (+0.04%)

Business Summary

GeoVax Labs Inc. is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle based vaccine platform. GeoVax Labs Inc. is based in ATLANTA, GA.

See More

Key Turning Points

3rd Resistance Point 0.8730
2nd Resistance Point 0.8265
1st Resistance Point 0.7942
Last Price 0.7620
1st Support Level 0.7154
2nd Support Level 0.6689
3rd Support Level 0.6366

See More

52-Week High 20.0000
Fibonacci 61.8% 12.6040
Fibonacci 50% 10.3194
Fibonacci 38.2% 8.0348
Last Price 0.7620
52-Week Low 0.6388

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.